(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RHINOZYN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RHINOZYN

ST13

US500000079266524

Class

1, 5

Filing

79266524

Registration

6197454

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

04/24/2026

Trademark type

Word

Nice classes

1, 5

Filing date

06/03/2019

Registration date

11/17/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/17/2020

Last transaction

04/24/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

CH

Examiner

EISNACH, MICHAEL PATRICK

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Bluestone Pharma GmbH

Representatives

Devasena Reddy

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Probiotic bacterial formulations being other than for medical use not to be administered or ingested nasallyprobiotic bacteria and probiotic bacterial cultures for use as ingredient for food and beverages; chemicals used in industry not to be administered or ingested nasally; chemical substances for preserving foodstuffs not to be administered or ingested nasally

Class 5

Probiotic bacterial formulations for medical use not to be administered or ingested nasally; dietary supplements and dietetic preparations in the nature of dietetic foods adapted for medical use not to be administered or ingested nasally; chewing gum for medical purposes; pharmaceutical preparations not to be administered or ingested nasallypharmaceutical preparations for the treatment of allergic rhinitis; dietetic foods for medicinal purposes; dietetic products for medical purposesdietetic preparations in the nature of food adapted for medical use; dietetic substances in the nature of food adapted for medical use; dietary supplements; bacterial preparations for medical use not to be administered or ingested nasally

Publications

History of USPTO decisions and trademark events.

42 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/23/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

11/17/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/21/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/26/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

02/26/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/26/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/26/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/25/2021

FIMP

FINAL DISPOSITION PROCESSED

02/25/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/22/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/22/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

02/22/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/22/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/22/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/22/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/17/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

11/17/2020

CHPB

POST PUBLICATION AMENDMENT - ENTERED

10/11/2020

APET

ASSIGNED TO PETITION STAFF

10/08/2020

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

08/27/2020

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

08/21/2020

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

03/13/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/18/2020

PUBO

PUBLISHED FOR OPPOSITION

02/18/2020

GPNX

NOTIFICATION PROCESSED BY IB

02/14/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/29/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/29/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/29/2020

ALIE

ASSIGNED TO LIE

01/14/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/13/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/10/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/10/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/10/2020

RFNT

REFUSAL PROCESSED BY IB

10/12/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/26/2019

RFRR

REFUSAL PROCESSED BY MPU

09/26/2019

MAFR

APPLICATION FILING RECEIPT MAILED

09/17/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/13/2019

CNRT

NON-FINAL ACTION WRITTEN

09/12/2019

DOCK

ASSIGNED TO EXAMINER

09/11/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/11/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/05/2019

Continuous trademark protection

Get notified about every new filing that threatens RHINOZYN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.